Promising drug cocktail targets tough sarcomas in young patients

NCT ID NCT02945800

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a combination of two chemotherapy drugs, nab-paclitaxel and gemcitabine, in 59 teenagers and young adults whose sarcoma (a type of bone or soft tissue cancer) had returned or not responded to standard treatment. The main goals were to see if the drug combo could shrink tumors or stop them from growing, and to check how safe and tolerable the treatment was. Participants received the drugs in cycles, and their tumors were measured with scans every two cycles.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EWING SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • A.I. duPont Hospital for Children, Delaware - Nemours

    Wilmington, Delaware, 19603, United States

  • Carolinas Medical Center, Levine Cancer Institute

    Charlotte, North Carolina, 28303, United States

  • Children's Hospital Los Angeles

    Los Angeles, California, 90027, United States

  • Connecticut Children's Medical Center

    Hartford, Connecticut, 06103, United States

  • H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center

    Tampa, Florida, 33612, United States

  • Holtz Children's Hospital at the University of Miami

    Miami, Florida, 33136, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Nemours Children's Clinic

    Jacksonville, Florida, 32207, United States

  • Shand's Hospital for Children at the University of Florida

    Gainesville, Florida, 32608, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, 21231, United States

  • University of Alabama at Birmingham Comprehensive Cancer Center

    Birmingham, Alabama, 35294, United States

  • University of Kentucky

    Lexington, Kentucky, 40506, United States

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, 27599, United States

  • Vanderbilt - Ingram Cancer Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.